Breast Cancer Clinical Program Archives - Page 23 of 27

The Metastatic Breast Cancer Network (MBCN) held its 8th Annual National Conference in Chapel Hill September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center.

Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that UNC researcher Zefeng Wang, PhD, discovered is drastically reduced in human lung and breast cancer cells.

UNC Lineberger Comprehensive Cancer Center researchers have developed a new integrated approach to pinpoint the genetic “drivers” of cancer, uncovering eight genes that could be viable for targeted breast cancer therapy. The study, published online August 24 in Nature Genetics, was authored by Michael Gatza, PhD, lead author and post-doctoral research associate; Grace Silva, graduate student; Joel Parker, PhD, director of bioinformatics, UNC Lineberger; Cheng Fan, research associate; and senior author Chuck Perou, PhD, professor of genetics and pathology.

Obesity, epidemic in the U.S. and worldwide, is one of the important modifiable risk factors for breast cancer, especially a particularly aggressive subtype called basal-like breast cancer (BBC). Population studies have suggested that lifestyle interventions, including weight loss, could prevent a large proportion of this type of cancer; however, data on the effect of weight loss on BBC risk are limited and the mechanisms involved uncertain.

Physical activity after breast cancer diagnosis has been linked with prolonged survival and improved quality of life, but most participants in a large breast cancer study did not meet national physical activity guidelines after they were diagnosed.

New research by Stephanie B. Wheeler, PhD; Katie Reeder-Hayes, MD; and Anne Marie Meyer, PhD, reveals that breast cancer patients insured by Medicaid and African-American breast cancer patients are less likely to receive life-saving endocrine therapy (ET) to prevent cancer recurrence.

The UCRF, a $42 million, state-appropriated fund established in 2007, continues to have a significant impact on cancer research in North Carolina.

The 2014 Susan G. Komen Triangle Race for the Cure is scheduled for Saturday, June 14th on the campus of Meredith College in Raleigh, NC.

The Susan G. Komen North Carolina Triangle to the Coast (NCTC) has awarded a $50,000 grant to UNC Lineberger Comprehensive Cancer Support Program to fund a project aimed at improving access to comprehensive lymphedema care for breast cancer patients in central North Carolina.

Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer

Tag: Breast Cancer Clinical Program

UNC Lineberger hosts Metastatic Breast Cancer Network Conference

UNC researchers find new genetic target for a different kind of cancer drug

UNC Lineberger researchers develop new approach to identify “drivers” of cancer

Study in mice finds weight loss reduces progression of basal-like breast cancer

Most Breast Cancer Patients May Not Be Getting Enough Exercise

Wheeler and Reeder-Hayes research shows African-American women and those insured by Medicaid less likely to receive endocrine therapy to prevent breast cancer recurrence

2013-2014 University Cancer Research Fund Annual Report now available

Join the UNC/Rex team for 2014 Susan G. Komen Triangle Race for the Cure!

Susan G. Komen for the Cure North Carolina Triangle to the Coast Affiliate awards $50,000 grant to UNC Lineberger Comprehensive Cancer Support Program

Solving Cancer’s Secrets: 5 Questions with Dr. Chuck Perou